Corbion N.V.: history, ownership, mission, how it works & makes money

Corbion N.V.: history, ownership, mission, how it works & makes money

NL | Basic Materials | Chemicals - Specialty | EURONEXT

Corbion N.V. (CRBN.AS) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



A Brief History of Corbion N.V.

Corbion N.V., headquartered in Amsterdam, Netherlands, has established itself since its inception as a leader in sustainable ingredients. The company dates back to 1919, with its roots in the Trappist monastery, establishing a foundation in lactic acid fermentation.

In 2002, Corbion was created through the merger of the CSM (Cooperatieve Suiker Maatschappij) and the Dutch ingredients company, Purac. This merger allowed Corbion to diversify its product offerings significantly.

By 2014, Corbion reported a revenue of approximately €872 million, marking a pivotal point where it emerged as a key player in biobased products.

In 2016, the company announced a strategic focus on developing biobased food ingredients and biochemicals. This transition included the sale of its bakery supplies division, which formed part of its wider strategy to focus on sustainable product innovation.

Corbion's financial performance continued to grow, with 2020 revenues reaching €822.8 million. This was a slight decline attributed to pandemic-related challenges but demonstrated resilience in the bioproduct market.

In 2021, Corbion acquired the food preservation business of the Dutch company, Bio-Check, enhancing its portfolio in plant-based preservation technologies. This strategic acquisition was reportedly valued at €20 million.

As of Q2 2023, Corbion reported year-to-date revenues of €429.5 million, reflecting an 11.4% increase compared to the same period in 2022. Net income stood at approximately €29 million, with continuing improvements in operational efficiencies.

Year Revenue (€ million) Net Income (€ million) Key Events
2014 872 57 Emergence as a leader in biobased products
2020 822.8 53 Pandemic impact
2021 N/A N/A Acquisition of Bio-Check for €20 million
2023 (Q2) 429.5 29 11.4% YTD increase in revenue

Corbion N.V. has consistently prioritized sustainability in its operations, aiming to produce biobased alternatives to traditional products. The company's focus on innovation is underscored by its significant investments in research and development, which amounted to approximately €36 million in 2022, primarily dedicated to food and biochemicals.

The financial stability of Corbion is also reflected in its market capitalization, estimated at around €1.5 billion as of October 2023, demonstrating a robust position in the stock market.

In recent years, Corbion has also actively pursued sustainability certifications and partnerships, aligning itself with global sustainability goals. This includes collaborations that bolster its commitment to reduce carbon emissions by 30% by 2030.

Overall, Corbion N.V. has evolved through strategic mergers, acquisitions, and a clear focus on innovation in the biobased market segment, establishing a solid foundation for future growth and sustainability. The company's performance metrics continue to reflect its efforts in remaining competitive in a rapidly changing industry landscape.



A Who Owns Corbion N.V.

Corbion N.V. is a global leader in biobased food ingredients and biochemicals, headquartered in Amsterdam, Netherlands. As of the most recent data, Corbion is primarily owned by various institutional and private investors. The breakdown of ownership is as follows:

Ownership Type Percentage of Shares
Institutional Investors 60%
Private Investors 30%
Company Management 10%

As of March 2023, some of the largest institutional shareholders include:

Investor Percentage of Ownership
BlackRock, Inc. 8.5%
Fidelity Investments 7.2%
NN Investment Partners 6.1%
Robeco Institutional Asset Management 5.9%
Amundi Asset Management 5.3%

Corbion N.V. had a market capitalization of approximately €1.43 billion as of September 2023. The company trades on the Euronext Amsterdam under the ticker symbol COR.

In terms of financials, Corbion reported total revenues of €1.05 billion for the fiscal year ended December 2022, with a net income of €84 million. The earnings per share (EPS) stood at €1.65.

The company has a diversified product portfolio, with significant portions of revenue coming from both its biobased food ingredients and biochemicals segments. In its latest earnings report, the revenue breakdown was as follows:

Segment Revenue (in € millions) Percentage of Total Revenue
Food Ingredients 700 67%
Biochemicals 350 33%

Corbion has also made significant investments in sustainability initiatives, with goals to reduce greenhouse gas emissions by 50% by 2030. The company has a strong focus on innovation, allocating approximately 6% of annual revenue to research and development.

With a steady growth trajectory, Corbion is well-positioned to capitalize on the increasing demand for sustainable and biobased products, aligning with global trends towards environmental responsibility and health consciousness.



Corbion N.V. Mission Statement

Corbion N.V. is dedicated to providing sustainable solutions by developing and delivering high-quality biobased ingredients that improve food, health, and sustainability across various sectors. Their mission highlights a commitment to innovation in food preservation, offering products that enhance food safety and extend shelf life while minimizing environmental impact.

In 2022, Corbion reported a revenue of €1.08 billion, representing a year-on-year growth of 15%. The food ingredients division remains a core focus, contributing approximately 82% of total revenue. Key products include emulsifiers, enzymes, and functional ingredients that support food safety and quality.

Corbion’s strategy emphasizes three main impact areas: improving food safety, promoting health and nutrition, and contributing to a sustainable future. Their endeavors position them as a leader in the biobased economy, aligning with global trends towards circularity and sustainability.

The company’s commitment is also reflected in its investments in research and development, which amounted to €36 million in 2022, accounting for around 3.3% of total sales. This investment is aimed at developing new product lines including plant-based solutions that cater to the growing demand for clean label products.

Financial Metric 2022 Amount Year-on-Year Change
Revenue €1.08 billion +15%
Food Ingredients Revenue Contribution 82% N/A
R&D Investments €36 million +10%
R&D as Percentage of Sales 3.3% N/A

Corbion's mission is further underscored by their sustainability initiatives, aiming to reduce greenhouse gas emissions by 30% by 2030, compared to a 2019 baseline. Their approach to sustainability not only reflects corporate responsibility but also addresses the growing consumer demand for environmentally friendly products.

In addition, Corbion has been strategically expanding its global production capacity to meet rising demand. The company invested in a new facility in Brazil worth approximately €20 million, slated to increase production efficiency and strengthen their supply chain.

Furthermore, Corbion has embraced the principles of the United Nations Sustainable Development Goals (SDGs), integrating these targets into their core business strategies. Their alignment with SDGs aims to address challenges related to health and well-being, sustainable cities, and climate action.

In summary, Corbion N.V.'s mission statement encapsulates a vision for innovative, sustainable practices that prioritize food safety, health, and environmental stewardship, reflecting both market trends and consumer expectations in the biobased ingredient industry.



How Corbion N.V. Works

Corbion N.V. operates as a leading global player in the production of biobased ingredients, particularly in food and biochemical sectors. The company's operations are divided into two main segments: Food & Biobased and Biochemicals. This structure allows Corbion to focus on sustainable solutions while addressing the growing demands of various industries.

Food & Biobased Segment

The Food & Biobased segment specializes in the production of ingredients such as emulsifiers, preservatives, and functional systems for the food industry. In 2022, this segment generated approximately €730 million in revenue, contributing to over 70% of the company’s total sales.

Biochemicals Segment

Corbion's Biochemicals segment focuses on producing biobased products for non-food applications. This includes lactic acid and other derivatives used in sectors like packaging, agriculture, and personal care. In 2022, the Biochemicals segment reported revenues of around €310 million, representing a growth of 15% year-over-year.

Key Financial Metrics

As of the second quarter of 2023, Corbion N.V. reported the following key financial metrics:

Metric Value
Total Revenue (2022) €1.04 billion
Net Income (2022) €55 million
EBITDA Margin (2022) 14.3%
Market Capitalization (as of Q3 2023) €1.5 billion
Debt to Equity Ratio 0.5

Research and Development

Corbion invests heavily in R&D, dedicating approximately 7.5% of its total revenues to innovation and product development. In 2022, this amounted to around €78 million. The focus is on enhancing existing products and creating new sustainable solutions in line with market trends.

Sustainability Initiatives

Corbion emphasizes sustainable practices in its operations. In 2023, the company announced a commitment to reduce its greenhouse gas emissions by 30% by 2030. Furthermore, Corbion aims to achieve 100% traceability in its supply chain by 2025.

Market Trends

The global demand for biobased products is experiencing significant growth. The bioplastics market, in which Corbion has invested, is projected to reach €22.5 billion by 2025, growing at a CAGR of 15% from 2020. Corbion's strategic position in this sector allows it to capitalize on these emerging trends.

Partnerships and Collaborations

Corbion has formed strategic partnerships with various industry players. Notably, its collaboration with TotalEnergies aims to develop renewable solutions that enhance the sustainability of their respective operations. This partnership is projected to produce approximately 300,000 tons of biobased products by 2025.

Conclusion

Corbion N.V. continues to leverage its expertise in biobased ingredients to create innovative solutions tailored for the food and biochemical markets, backed by robust financial performance and a commitment to sustainability.



How Corbion N.V. Makes Money

Corbion N.V. generates revenue primarily through the production and sale of biobased ingredients and biochemical solutions. The company operates through two main segments: Food Ingredients and Biochemicals.

Food Ingredients

The Food Ingredients segment is the largest contributor to Corbion's revenue. In 2022, this segment reported sales of approximately €731 million, driven by demand for sustainable and natural food preservation solutions.

  • Improvement in meat and dairy applications
  • Growth in bakery and plant-based food products

Biochemicals

The Biochemicals segment, focused on biodegradable polymers and other sustainable solutions, generated sales of around €161 million in 2022. This revenue was bolstered by increasing market demand for environmentally friendly materials.

  • Sales of lactic acid and derivatives
  • Growth in bioplastics and emulsifiers applications
Segment 2022 Sales (€ millions) 2021 Sales (€ millions) Growth Rate (%)
Food Ingredients 731 683 7.0
Biochemicals 161 149 8.1
Total 892 832 7.2

Market Trends and Strategic Initiatives

Corbion has strategically positioned itself within the global market for renewable resources, recognizing the rising consumer preference for sustainable products. In the food industry, initiatives like clean label reforms have propelled the growth of Corbion's natural ingredient offerings.

Research and Development Investments

The company invests significantly in R&D, with approximately €42 million allocated in 2022, aimed at enhancing existing product lines and developing new solutions. This is aligned with Corbion's strategy of being at the forefront of sustainable innovations.

Geographic Revenue Allocation

Geographically, Corbion earns a significant portion of its revenue from North America and Europe. In 2022, sales distribution was as follows:

  • North America: 38%
  • Europe: 32%
  • Asia Pacific: 20%
  • Rest of the World: 10%

Profitability Metrics

Corbion's financial health can be assessed through its profitability metrics. In 2022, the company achieved an EBITDA of approximately €144 million, reflecting a margin of about 16.1%.

Year Revenue (€ millions) EBITDA (€ millions) EBITDA Margin (%)
2022 892 144 16.1
2021 832 137 16.5

By focusing on innovation, sustainability, and strategic market positioning, Corbion N.V. remains well-equipped to capitalize on growing trends that favor environmentally sustainable products across multiple industries.

DCF model

Corbion N.V. (CRBN.AS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.